Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000260841

Medchemexpress LLC Au-15330 | 2380274-50-8 | 99.9% | C39H49N9O5S | 10MG
SDP

Supplier:  Medchemexpress LLC HY14538810MG

Encompass_Preferred

AU-15330 is a proteolysis-targeting chimera (PROTAC) that selectively degrades SWI/SNF ATPase subunits SMARCA2 and SMARCA4. It demonstrates potent antitumor activity in prostate cancer xenograft models and shows synergy with androgen receptor antagonists in preclinical studies.

  • Selective degradation of SMARCA2 and SMARCA4
  • Demonstrated antitumor activity in prostate cancer xenograft models
  • Synergizes with androgen receptor antagonists
  • High reported purity (≈99.9%) suitable for research use
  • Solid, off-white to yellow appearance for easy handling
  • Storage-stable when kept under recommended conditions

Catalog No. 50-002-60841


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.